Seer (SEER) Equity Average (2020 - 2026)
Seer (SEER) recorded quarterly Equity Average of $250.4 million in Q1 2026, down 5.71% quarter-over-quarter from $265.6 million in Q4 2025, and down 21.58% on a YoY basis from $319.3 million in Q1 2025.
Seer (SEER) Equity Average (2020 - 2026) Analysis & Trends
Seer's Equity Average history runs 7 years deep, the most recent figure standing at $250.4 million for Q1 2026.
- In Q1 2026, Equity Average fell 21.58% year-over-year to $250.4 million; the TTM figure through Mar 2026 stood at $250.4 million (down 21.58% YoY), while the FY2025 annual figure was $293.4 million, down 18.99% from the prior year.
- Equity Average was $250.4 million for Q1 2026 at Seer, down from $265.6 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $494.7 million in Q1 2022 to a low of $250.4 million in Q1 2026.
- Historically, Equity Average has averaged $378.8 million across 5 years, with a median of $390.2 million in 2024.
- The sharpest annual moves came in 2022 and 2026: Equity Average increased 2.27% in 2022, then fell 21.58% in 2026.
- A 5-year view of Equity Average shows it stood at $452.4 million in 2022, then slipped by 11.29% to $401.3 million in 2023, then fell by 16.23% to $336.1 million in 2024, then fell by 21.0% to $265.6 million in 2025, then declined by 5.71% to $250.4 million in 2026.
- The last three Equity Average figures came in at $250.4 million (Q1 2026), $265.6 million (Q4 2025), and $280.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 21.35 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 516.41 Mn |
| 10 | Seer | 95.75 Mn | 95.75 Mn | 982,000.00 | 250.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 250.39 Mn |
| Dec 31, 2025 | 265.56 Mn |
| Sep 30, 2025 | 280.05 Mn |
| Jun 30, 2025 | 299.65 Mn |
| Mar 31, 2025 | 319.29 Mn |
| Dec 31, 2024 | 336.15 Mn |
| Sep 30, 2024 | 354.71 Mn |
| Jun 30, 2024 | 374.13 Mn |
| Mar 31, 2024 | 390.23 Mn |
| Dec 31, 2023 | 401.29 Mn |
| Sep 30, 2023 | 411.90 Mn |
| Jun 30, 2023 | 425.55 Mn |
| Mar 31, 2023 | 439.99 Mn |
| Dec 31, 2022 | 452.38 Mn |
| Sep 30, 2022 | 464.91 Mn |
| Jun 30, 2022 | 479.25 Mn |
| Mar 31, 2022 | 494.69 Mn |
| Dec 31, 2021 | 509.06 Mn |
| Sep 30, 2021 | 520.62 Mn |
| Jun 30, 2021 | 530.91 Mn |